These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

151 related articles for article (PubMed ID: 20516464)

  • 41. Heterogeneous impact of methadone on the QTc interval: what are the practical implications?
    Krantz MJ
    J Addict Dis; 2008; 27(4):5-9. PubMed ID: 19042586
    [TBL] [Abstract][Full Text] [Related]  

  • 42. QT or not QT, that is the question: routine electrocardiograms for individuals in methadone maintenance treatment.
    Stimmel B
    J Addict Dis; 2011 Oct; 30(4):307-8. PubMed ID: 22026520
    [No Abstract]   [Full Text] [Related]  

  • 43. A twist on torsade: a prolonged QT interval on methadone.
    Lamont P; Hunt SC
    J Gen Intern Med; 2006 Nov; 21(11):C9-C12. PubMed ID: 17026725
    [TBL] [Abstract][Full Text] [Related]  

  • 44. First, do no harm: QT interval screening in methadone maintenance treatment.
    Haigney MC
    J Addict Dis; 2011 Oct; 30(4):309-12. PubMed ID: 22026521
    [No Abstract]   [Full Text] [Related]  

  • 45. Methadone maintenance, QTc and torsade de pointes: who needs an electrocardiogram and what is the prevalence of QTc prolongation?
    Mayet S; Gossop M; Lintzeris N; Markides V; Strang J
    Drug Alcohol Rev; 2011 Jul; 30(4):388-96. PubMed ID: 21355918
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Methadone death, dosage and torsade de pointes: risk-benefit policy implications.
    Latowsky M
    J Psychoactive Drugs; 2006 Dec; 38(4):513-9. PubMed ID: 17373567
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Ventricular arrhythmias in patients treated with methadone for opioid dependence.
    Hanon S; Seewald RM; Yang F; Schweitzer P; Rosman J
    J Interv Card Electrophysiol; 2010 Jun; 28(1):19-22. PubMed ID: 20177760
    [TBL] [Abstract][Full Text] [Related]  

  • 48. QT interval prolongation: prevalence, risk factors and pharmacovigilance data among methadone-treated patients in France.
    Perrin-Terrin A; Pathak A; Lapeyre-Mestre M
    Fundam Clin Pharmacol; 2011 Aug; 25(4):503-10. PubMed ID: 20825488
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Drug-induced long QT in adult psychiatric inpatients: the 5-year cross-sectional ECG Screening Outcome in Psychiatry study.
    Girardin FR; Gex-Fabry M; Berney P; Shah D; Gaspoz JM; Dayer P
    Am J Psychiatry; 2013 Dec; 170(12):1468-76. PubMed ID: 24306340
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Electrocardiogram characteristics of methadone and buprenorphine maintained subjects.
    Athanasos P; Farquharson AL; Compton P; Psaltis P; Hay J
    J Addict Dis; 2008; 27(3):31-5. PubMed ID: 18956527
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Treatment of methadone-induced torsades de pointes with lidocaine.
    Rajpal S; Mundi AS; Reddy PC; Akkus NI
    J La State Med Soc; 2013; 165(6):338-41. PubMed ID: 25073261
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Hypokalemia in women and methadone therapy are the strongest non-cardiologic factors associated with QT prolongation in an emergency department setting.
    Marill KA; Miller ES
    J Electrocardiol; 2017; 50(4):416-423. PubMed ID: 28274542
    [TBL] [Abstract][Full Text] [Related]  

  • 53. [Torsade de Pointes in patient infected with human immunodeficiency virus and treated with methadone].
    Moral Moral P; Rueda Soriano J; Tasias Pitarch M; Calbuig Alborch JR
    An Med Interna; 2006 Aug; 23(8):397-8. PubMed ID: 17089463
    [No Abstract]   [Full Text] [Related]  

  • 54. Cocaine-related torsade de pointes in a methadone maintenance patient.
    Krantz MJ; Rowan SB; Mehler PS
    J Addict Dis; 2005; 24(1):53-60. PubMed ID: 15774410
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Syncope: a tale of two triggers.
    Katz DF; Varosy PD; Masoudi FA
    JAMA Intern Med; 2013 Sep; 173(16):1543-4. PubMed ID: 24030761
    [No Abstract]   [Full Text] [Related]  

  • 56. Torsades de pointes and self-terminating ventricular fibrillation in a prescription methadone user.
    Atkinson D; Dunne A; Parker M
    Anaesthesia; 2007 Sep; 62(9):952-5. PubMed ID: 17697226
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Increased incidence of QT interval prolongation in a population receiving lower doses of methadone maintenance therapy.
    Roy AK; McCarthy C; Kiernan G; McGorrian C; Keenan E; Mahon NG; Sweeney B
    Addiction; 2012 Jun; 107(6):1132-9. PubMed ID: 22168435
    [TBL] [Abstract][Full Text] [Related]  

  • 58. QT prolongation and Torsades de Pointes in patients previously treated with anthracyclines.
    Arbel Y; Swartzon M; Justo D
    Anticancer Drugs; 2007 Apr; 18(4):493-8. PubMed ID: 17351403
    [TBL] [Abstract][Full Text] [Related]  

  • 59. CSAT's QT interval screening in methadone report: outrageous fortune or sea of troubles?
    Bart G
    J Addict Dis; 2011 Oct; 30(4):313-7. PubMed ID: 22026522
    [No Abstract]   [Full Text] [Related]  

  • 60. Role of implantable cardioverter-defibrillators in patients with methadone-induced long QT syndrome.
    Patel AM; Singh JP; Ruskin JN
    Am J Cardiol; 2008 Jan; 101(2):209-11. PubMed ID: 18178408
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.